NDC 55289-475-28 - CELEBREX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-475
- Requested NDC
- 55289-475-28
- Package NDCs from labels
- 55289-475-10, 55289-475-14, 55289-475-20, 55289-475-30, 55289-475-60, 55289-475-90, 55289-475-93, 55289-475-28
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Effective date
- 2022-03-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CELEBREX - PD-Rx Pharmaceuticals, Inc. | PD-Rx Pharmaceuticals, Inc. | 2022-03-11 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-475-10 | EA - Each | 55289-475 | cccc9f59-6a98-4cc0-bc36-2a84ccf0754e | 1 | 2012-07-24 |
| 55289-475-14 | EA - Each | 55289-475 | 100db08e-07e4-4df7-937a-91d0d56b0e04 | 1 | 2012-07-24 |
| 55289-475-20 | EA - Each | 55289-475 | 68790c93-cc43-4951-a484-ad86b4059028 | 1 | 2012-07-24 |
| 55289-475-28 | EA - Each | 55289-475 | 935ae5a2-d228-48bd-adc8-78802a8dfef5 | 1 | 2012-07-24 |
| 55289-475-30 | EA - Each | 55289-475 | c48b96dc-21f9-48d5-bf5f-69781d33cfcb | 1 | 2012-07-24 |
| 55289-475-60 | EA - Each | 55289-475 | 54574442-94fb-46db-9e83-e7fa3d3d6f2d | 1 | 2012-07-24 |
| 55289-475-90 | EA - Each | 55289-475 | 0b4de4cd-b90e-4403-9fa9-cf015da3b9ef | 1 | 2012-07-24 |
| 55289-475-93 | EA - Each | 55289-475 | 1aab94c1-ea71-4313-b627-3756fc366e93 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Celecoxib | ACTIVE INGREDIENT | JCX84Q7J1L | CELEBREX (CELECOXIB) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| Celecoxib | ACTIVE MOIETY | JCX84Q7J1L | CELEBREX (CELECOXIB) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | CELEBREX (CELECOXIB) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | CELEBREX (CELECOXIB) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| lactose monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | CELEBREX (CELECOXIB) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | CELEBREX (CELECOXIB) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| povidone | INACTIVE INGREDIENT | FZ989GH94E | CELEBREX (CELECOXIB) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | CELEBREX (CELECOXIB) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 8 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Celecoxib | CELECOXIB | Cardinal Health 107, LLC | a9114d6a-13d7-443c-be44-7866b4a4cf96 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| celecoxib | CELECOXIB | HAWAII REPACK, INC. | 45816eae-ad83-4d2f-a035-c3f9f24708f9 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | HAWAII REPACK, INC. | 77f3b90b-a25d-4c47-975a-2a988d696a3f | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | St Mary's Medical Park Pharmacy | e1ab644d-b668-3cf3-e053-2995a90addb0 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Radha Pharmaceuticals, Inc. | 2c86ece8-1cf5-4688-91b1-8aef5d60b7e4 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Bryant Ranch Prepack | d94849a7-1831-4319-982c-c6b20dc42038 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Rohto Sun and Sport | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 8bcc8882-b886-4b55-9bc4-d4b92a41358f | 2026-06-19 | Warnings | FZ989GH94E |
| Rohto Dual Light Relief | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 1b597f83-d7f1-cf93-e063-6394a90a99f7 | 2026-06-19 | Warnings | FZ989GH94E |
| celecoxib | CELECOXIB | PD-Rx Pharmaceuticals, Inc. | 78d59905-4a78-4d9f-ac29-58790a5b3a92 | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Ripple | GLYCERIN, POVIDONE | CorneaCare Inc | 3b5ba197-d501-681e-e063-6294a90aefb5 | 2026-05-24 | Warnings | FZ989GH94E |
| CELECOXIB | CELECOXIB | Bryant Ranch Prepack | fd569104-8243-48fa-8e93-5a08654ad6dd | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Redpharm Drug | 5250529a-6a03-78a1-e063-6294a90a47f9 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | PD-Rx Pharmaceuticals, Inc. | 52572bfb-43f0-4b55-b1fd-231a05c8b83e | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | AvPAK | 951df0f7-5fb7-40f5-e053-2995a90a1edd | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| celecoxib | CELECOXIB | Macleods Pharmaceuticals Limited | d14aecf5-16e9-459a-bda4-4ca8f290796a | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | REMEDYREPACK INC. | 56d64558-1fad-420e-8fcd-7103cd073127 | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | ST. MARY'S MEDICAL PARK PHARMACY | ed2093f6-1606-100a-e053-2995a90a5b95 | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| iVIZIA Lubricant Eye Gel | POVIDONE | Thea Pharma Inc. | 1f06ca1a-5270-9a82-e063-6294a90aed64 | 2026-04-29 | Warnings | FZ989GH94E |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Preferred PHarmaceuticals Inc. | 011473a8-26d5-4661-b3c0-745f9b6aa1d8 | 2026-04-29 | Warnings | FZ989GH94E |
| Celecoxib | CELECOXIB | REMEDYREPACK INC. | 56127f57-7810-4f5d-a11d-e08fb2ed138b | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.